Titre : Immunosuppresseurs

Immunosuppresseurs : Questions médicales fréquentes

Termes MeSH sélectionnés :

Language Development Disorders
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Immunosuppresseurs : Questions médicales les plus fréquentes", "headline": "Immunosuppresseurs : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Immunosuppresseurs : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-27", "dateModified": "2025-04-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Immunosuppresseurs" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Facteurs immunologiques", "url": "https://questionsmedicales.fr/mesh/D007155", "about": { "@type": "MedicalCondition", "name": "Facteurs immunologiques", "code": { "@type": "MedicalCode", "code": "D007155", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.477" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs du complément", "alternateName": "Complement Inactivating Agents", "url": "https://questionsmedicales.fr/mesh/D051056", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du complément", "code": { "@type": "MedicalCode", "code": "D051056", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.477.656.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antagonistes du récepteur B2 de la bradykinine", "alternateName": "Bradykinin B2 Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065094", "about": { "@type": "MedicalCondition", "name": "Antagonistes du récepteur B2 de la bradykinine", "code": { "@type": "MedicalCode", "code": "D065094", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.477.656.500.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des interleukines", "alternateName": "Interleukin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000088902", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des interleukines", "code": { "@type": "MedicalCode", "code": "D000088902", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.477.656.563" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'interleukine-6", "alternateName": "Interleukin-6 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000093242", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'interleukine-6", "code": { "@type": "MedicalCode", "code": "D000093242", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.477.656.594" } } }, { "@type": "MedicalWebPage", "name": "Modulateurs des récepteurs de la sphingosine 1 phosphate", "alternateName": "Sphingosine 1 Phosphate Receptor Modulators", "url": "https://questionsmedicales.fr/mesh/D000081243", "about": { "@type": "MedicalCondition", "name": "Modulateurs des récepteurs de la sphingosine 1 phosphate", "code": { "@type": "MedicalCode", "code": "D000081243", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.696.477.656.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Immunosuppresseurs", "alternateName": "Immunosuppressive Agents", "code": { "@type": "MedicalCode", "code": "D007166", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Koichi Kamei", "url": "https://questionsmedicales.fr/author/Koichi%20Kamei", "affiliation": { "@type": "Organization", "name": "Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan. kamei-k@ncchd.go.jp." } }, { "@type": "Person", "name": "Masao Ogura", "url": "https://questionsmedicales.fr/author/Masao%20Ogura", "affiliation": { "@type": "Organization", "name": "Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan." } }, { "@type": "Person", "name": "Kensuke Shoji", "url": "https://questionsmedicales.fr/author/Kensuke%20Shoji", "affiliation": { "@type": "Organization", "name": "Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan." } }, { "@type": "Person", "name": "Shuichi Ito", "url": "https://questionsmedicales.fr/author/Shuichi%20Ito", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, Yokohama City University Hospital, Kanagawa, Japan." } }, { "@type": "Person", "name": "Dorota Iwaszkiewicz-Grześ", "url": "https://questionsmedicales.fr/author/Dorota%20Iwaszkiewicz-Grze%C5%9B", "affiliation": { "@type": "Organization", "name": "Department of Medical Immunology, Faculty of Medicine, Medical University of Gdansk, ul. Dębinki 7, 80-210 Gdańsk, Poland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The Development of Mental Health Difficulties in Young People With and Without Developmental Language Disorder: A Gene-Environment Interplay Study Using Polygenic Scores.", "datePublished": "2023-04-11", "url": "https://questionsmedicales.fr/article/37040695", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2023_JSLHR-22-00664" } }, { "@type": "ScholarlyArticle", "name": "Music skills of Spanish-speaking children with developmental language disorder.", "datePublished": "2023-07-27", "url": "https://questionsmedicales.fr/article/37515985", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ridd.2023.104575" } }, { "@type": "ScholarlyArticle", "name": "Auditory brainstem response deficits in learning disorders and developmental language disorder: a systematic review and meta-analysis.", "datePublished": "2022-11-22", "url": "https://questionsmedicales.fr/article/36418364", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-20438-7" } }, { "@type": "ScholarlyArticle", "name": "Performance in decoding and writing of children with Developmental Language Disorder: preliminary data.", "datePublished": "2023-10-23", "url": "https://questionsmedicales.fr/article/37878958", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/2317-1782/20232022318pt" } }, { "@type": "ScholarlyArticle", "name": "Developmental Language Disorder and Writing: A Scoping Review From Childhood to Adulthood.", "datePublished": "2023-07-17", "url": "https://questionsmedicales.fr/article/37459603", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1044/2023_JSLHR-22-00583" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Effets physiologiques des médicaments", "item": "https://questionsmedicales.fr/mesh/D045505" }, { "@type": "ListItem", "position": 5, "name": "Facteurs immunologiques", "item": "https://questionsmedicales.fr/mesh/D007155" }, { "@type": "ListItem", "position": 6, "name": "Immunosuppresseurs", "item": "https://questionsmedicales.fr/mesh/D007166" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Immunosuppresseurs - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Immunosuppresseurs", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Immunosuppresseurs", "description": "Comment diagnostiquer une nécessité d'immunosuppresseurs ?\nQuels tests sont utilisés pour évaluer l'immunité ?\nQuels signes indiquent un besoin d'immunosuppresseurs ?\nComment évaluer le risque de rejet d'organe ?\nQuels symptômes nécessitent un traitement immunosuppresseur ?", "url": "https://questionsmedicales.fr/mesh/D007166?mesh_terms=Language+Development+Disorders&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Immunosuppresseurs", "description": "Quels sont les effets secondaires des immunosuppresseurs ?\nComment reconnaître une infection due à l'immunosuppression ?\nQuels symptômes d'allergie peuvent survenir ?\nLes immunosuppresseurs causent-ils des troubles digestifs ?\nQuels signes indiquent une réaction indésirable ?", "url": "https://questionsmedicales.fr/mesh/D007166?mesh_terms=Language+Development+Disorders&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Immunosuppresseurs", "description": "Comment prévenir les infections sous immunosuppression ?\nQuelles précautions alimentaires prendre ?\nComment gérer le stress pendant le traitement ?\nQuels examens de suivi sont nécessaires ?\nComment éviter les interactions médicamenteuses ?", "url": "https://questionsmedicales.fr/mesh/D007166?mesh_terms=Language+Development+Disorders&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Immunosuppresseurs", "description": "Quels types d'immunosuppresseurs existent ?\nComment sont administrés les immunosuppresseurs ?\nQuelle est la durée du traitement immunosuppresseur ?\nComment ajuster la posologie des immunosuppresseurs ?\nQuels sont les traitements alternatifs aux immunosuppresseurs ?", "url": "https://questionsmedicales.fr/mesh/D007166?mesh_terms=Language+Development+Disorders&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Immunosuppresseurs", "description": "Quelles sont les complications possibles des immunosuppresseurs ?\nComment reconnaître une infection grave ?\nLes immunosuppresseurs augmentent-ils le risque de cancer ?\nQuels troubles métaboliques peuvent survenir ?\nComment gérer les complications liées aux immunosuppresseurs ?", "url": "https://questionsmedicales.fr/mesh/D007166?mesh_terms=Language+Development+Disorders&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Immunosuppresseurs", "description": "Quels facteurs augmentent le besoin d'immunosuppresseurs ?\nComment l'âge influence-t-il le traitement ?\nLe mode de vie affecte-t-il l'immunosuppression ?\nQuels médicaments augmentent le risque d'interactions ?\nLes antécédents familiaux influencent-ils le traitement ?", "url": "https://questionsmedicales.fr/mesh/D007166?mesh_terms=Language+Development+Disorders&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une nécessité d'immunosuppresseurs ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation clinique et des tests sanguins pour évaluer l'auto-immunité." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'immunité ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme le dosage des anticorps et des lymphocytes T sont couramment utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent un besoin d'immunosuppresseurs ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des inflammations chroniques ou des éruptions cutanées peuvent indiquer ce besoin." } }, { "@type": "Question", "name": "Comment évaluer le risque de rejet d'organe ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation se fait par des tests de compatibilité et des marqueurs immunologiques." } }, { "@type": "Question", "name": "Quels symptômes nécessitent un traitement immunosuppresseur ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fatigue extrême ou des douleurs articulaires peuvent nécessiter un traitement." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des immunosuppresseurs ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent infections, fatigue, et troubles gastro-intestinaux." } }, { "@type": "Question", "name": "Comment reconnaître une infection due à l'immunosuppression ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme fièvre, frissons ou douleurs inhabituelles peuvent indiquer une infection." } }, { "@type": "Question", "name": "Quels symptômes d'allergie peuvent survenir ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées, démangeaisons ou gonflements peuvent être des signes d'allergie." } }, { "@type": "Question", "name": "Les immunosuppresseurs causent-ils des troubles digestifs ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des nausées, vomissements ou diarrhées peuvent survenir avec certains immunosuppresseurs." } }, { "@type": "Question", "name": "Quels signes indiquent une réaction indésirable ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des douleurs abdominales ou des saignements peuvent signaler une réaction." } }, { "@type": "Question", "name": "Comment prévenir les infections sous immunosuppression ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il est essentiel de se faire vacciner et d'éviter les contacts avec des personnes malades." } }, { "@type": "Question", "name": "Quelles précautions alimentaires prendre ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les aliments crus et assurez-vous que les aliments sont bien cuits pour prévenir les infections." } }, { "@type": "Question", "name": "Comment gérer le stress pendant le traitement ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques de relaxation et un soutien psychologique peuvent aider à gérer le stress." } }, { "@type": "Question", "name": "Quels examens de suivi sont nécessaires ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des examens réguliers de la fonction rénale et des tests sanguins sont nécessaires pour le suivi." } }, { "@type": "Question", "name": "Comment éviter les interactions médicamenteuses ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Informez toujours votre médecin de tous les médicaments que vous prenez pour éviter les interactions." } }, { "@type": "Question", "name": "Quels types d'immunosuppresseurs existent ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux types incluent les corticostéroïdes, les inhibiteurs de calcineurine et les agents biologiques." } }, { "@type": "Question", "name": "Comment sont administrés les immunosuppresseurs ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être administrés par voie orale, intraveineuse ou sous-cutanée selon le médicament." } }, { "@type": "Question", "name": "Quelle est la durée du traitement immunosuppresseur ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La durée varie selon la maladie, allant de quelques mois à plusieurs années." } }, { "@type": "Question", "name": "Comment ajuster la posologie des immunosuppresseurs ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La posologie est ajustée en fonction des résultats des tests sanguins et de la réponse clinique." } }, { "@type": "Question", "name": "Quels sont les traitements alternatifs aux immunosuppresseurs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements alternatifs incluent des thérapies biologiques et des médicaments anti-inflammatoires." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des immunosuppresseurs ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections graves, des cancers et des troubles métaboliques." } }, { "@type": "Question", "name": "Comment reconnaître une infection grave ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme une forte fièvre, des frissons ou une confusion peuvent indiquer une infection grave." } }, { "@type": "Question", "name": "Les immunosuppresseurs augmentent-ils le risque de cancer ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'utilisation prolongée d'immunosuppresseurs peut augmenter le risque de certains cancers." } }, { "@type": "Question", "name": "Quels troubles métaboliques peuvent survenir ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles comme le diabète ou l'hypertension peuvent survenir avec certains immunosuppresseurs." } }, { "@type": "Question", "name": "Comment gérer les complications liées aux immunosuppresseurs ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion implique un suivi régulier, des ajustements de traitement et une surveillance des symptômes." } }, { "@type": "Question", "name": "Quels facteurs augmentent le besoin d'immunosuppresseurs ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents de maladies auto-immunes ou de transplantation augmentent ce besoin." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le traitement ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées peuvent avoir un risque accru d'effets secondaires et nécessiter des ajustements." } }, { "@type": "Question", "name": "Le mode de vie affecte-t-il l'immunosuppression ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain peut réduire les risques d'infections et améliorer la réponse au traitement." } }, { "@type": "Question", "name": "Quels médicaments augmentent le risque d'interactions ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certains antibiotiques et antifongiques peuvent interagir avec les immunosuppresseurs." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le traitement ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies auto-immunes peuvent augmenter le risque de développer des maladies similaires." } } ] } ] }

Sources (10000 au total)

The Development of Mental Health Difficulties in Young People With and Without Developmental Language Disorder: A Gene-Environment Interplay Study Using Polygenic Scores.

Young people with developmental language disorder (DLD) have poorer mental health than those without DLD. However, not all young people with DLD are equally affected; some have more mental health diff... Data from a community cohort study, the Avon Longitudinal Study of Parents and Children, were analyzed to investigate genetic and environmental influences on the development of mental health difficult... Polygenic scores (PGSs), indices of genetic risk, for common psychiatric disorders (major depressive disorder, anxiety disorder, and attention deficit hyperactivity disorder) predicted mental health d... These findings suggest that, for the most part, both genetic and environmental risk affect the development of mental health difficulties in a cumulative way for young people with DLD (and those withou... https://doi.org/10.23641/asha.22351012....

Music skills of Spanish-speaking children with developmental language disorder.

According to temporal sampling theory, deficits in rhythm processing contribute to both language and music difficulties in children with developmental language disorder (DLD). Evidence for this propos... This research aimed to study a previously unexamined topic, namely, the music skills of children with DLD who speak Spanish (a syllable-timed language), and to analyze the possible relationships betwe... Two groups of 18 Spanish-speaking children with DLD and 19 typically-developing peers matched for chronological age completed a set of language tests. Their rhythm discrimination, melody discriminatio... Children with DLD exhibited significantly lower performance than their typically-developing peers on all three music subtests. Music and language skills were significantly related in both groups.... The results suggest that similar music difficulties may be found in children with DLD whether they speak stress-timed or syllable-timed languages. The relationships found between music and language sk...

Auditory brainstem response deficits in learning disorders and developmental language disorder: a systematic review and meta-analysis.

Although learning disorders (LD) and developmental language disorder (DLD) can be linked to overlapping psychological and behavioral deficits, such as phonological, morphological, orthographic, semant...

Performance in decoding and writing of children with Developmental Language Disorder: preliminary data.

to verify the performance of children with Developmental Language Disorder in decoding and writing tests in order to better understand their manifestations and the process of acquiring written languag... The study subjects were 80 children. The Research Group consisted of 16 children diagnosed with Developmental Language Disorder, 13 males and 3 females, mean age of 7.3. The Control Group counted on 6... The data indicated a longer decoding time and a lower percentage of correct answers for the children from the Research Group. Regarding spelling errors, there was a predominance of arbitrary spelling ... The data showed that children with Developmental Language Disorder tend to have a longer decoding time, greater percentage of errors than their peers and tend to present spelling errors more concentra...

Developmental Language Disorder and Writing: A Scoping Review From Childhood to Adulthood.

The purpose of this study was to conduct a scoping review of literature focused on the effects of developmental language disorder (DLD) on writing skills across the life span to highlight gaps in our ... We adopted the five-step framework for conducting scoping reviews outlined by Arksey and O'Malley (2005) to identify literature focused on writing outcomes for individuals with DLD in childhood, adole... Seventy-two studies from 1991 to 2022 met review criteria. Results indicated that spelling may be an area of relative weakness for individuals with DLD across the life span. Children and adolescents w... Overall, research into the writing skills of individuals with DLD is limited, and more information is needed to inform functional evidence-based approaches to assessment and intervention of writing fo... https://doi.org/10.23641/asha.23596797....

The contribution of theta and delta to feedback processing in children with developmental language disorder.

The study aimed at evaluating feedback processing at the electrophysiological level and its relation to learning in children with developmental language disorder (DLD) to further advance our understan... A feedback-based probabilistic learning task required children to classify novel cartoon animals into two categories that differ on five binary features, the probabilistic combination of which determi... Children with developmental language disorder (DLD) performed poorer on the task when compared with their age-matched peers with typical language development (TD). The electrophysiological data in the... Theta activity, which is associated with the initial processing of feedback at the level of the anterior cingulate cortex, was detected in children with developmental language disorder (DLD) but was n...

Direct Instruction Improves Word Learning for Children With Developmental Language Disorder.

The current study compared the effects of direct instruction versus indirect exposure on multiple aspects of novel word learning for children with developmental language disorder (DLD) and children wi... Participants included 36 children with DLD and 45 children with TLD. All children were in the first grade and 6-8 years of age (... In alternative forced-choice measures of recognition, children with DLD were less accurate than their TLD peers in linking words to referents, encoding semantic categories for words, and encoding deta... These results suggest that vocabulary interventions with direct instruction can help children with DLD learn some, but not all, aspects of novel words. Additional support is necessary to help children...